0001562180-22-005117.txt : 20220615
0001562180-22-005117.hdr.sgml : 20220615
20220615161227
ACCESSION NUMBER: 0001562180-22-005117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220613
FILED AS OF DATE: 20220615
DATE AS OF CHANGE: 20220615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldan Keith A.
CENTRAL INDEX KEY: 0001495411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 221017899
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-06-13
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001495411
Goldan Keith A.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
false
true
false
false
Chief Financial Officer
Common Stock
2022-06-13
4
A
false
3205.00
0.00
A
3205.00
D
Stock Options (Right to buy)
15.60
2022-06-13
4
A
false
230000.00
15.60
A
2032-06-13
Common Stock
230000.00
230000.00
D
Award of Restricted Stock Units that vest 50% of the shares on June 13, 2023 and the remaining 50% of the shares on June 13, 2024.
Twenty five percent (25%) of the total number of shares underlying the option shall vest on June 13, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
/s/ Michael A. Metzger, Attorney-in-Fact
2022-06-15